<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04043949</url>
  </required_header>
  <id_info>
    <org_study_id>DEDOQ</org_study_id>
    <nct_id>NCT04043949</nct_id>
  </id_info>
  <brief_title>The Influences of Dry Eye Disease on Optical Quality</brief_title>
  <official_title>The Influences of Dry Eye Disease on Optical Quality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      DED could result in visual disturbance and damage optical quality. We aimed to evaluate the
      influences of dry eye disease (DED) on optical quality and their correlations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is aimed at evaluating changes of optical quality in dry eye patients with
      superficial punctate keratopathy after being treated by artificial lubricant and
      anti-inflammatory eye drops.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Actual">July 1, 2018</completion_date>
  <primary_completion_date type="Actual">July 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The severity of DED influenced the optical quality of dry eye patients</measure>
    <time_frame>2017.7-2019.7</time_frame>
    <description>The optical quality of dry eye patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>High order abberations</measure>
    <time_frame>2017.7-2019.7</time_frame>
    <description>cornela high order abberations of patients</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Dry Eye</condition>
  <condition>Vision; Disturbance, Hysterical</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>healthy subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dry eye group</arm_group_label>
    <description>patients with dry eye</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dry eye after treatment</arm_group_label>
    <description>patients with dry eye after treatment</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Aged between 18-65 years old.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patients were diagnosed as dry eye according to the criteria provided by the Dry Eye
             Workshop (DEWS)

          2. positive corneal fluorescein staining (CFS)

          3. best-corrected distance visual acuity better than 20/20.

        Exclusion Criteria:

        History of ocular surgeries, contact lens wear, meibomian gland dysfunction, and any type
        of corneal scarring such as dystrophies or infections.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Qi, MD,Phd</last_name>
    <role>Study Chair</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <study_first_submitted>December 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2019</study_first_posted>
  <last_update_submitted>July 31, 2019</last_update_submitted>
  <last_update_submitted_qc>July 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

